ADVA
8.6.2022 09:02:06 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Partner Communications has deployed its Oscilloquartz timing technology to support 5G rollout throughout Israel. The solution provides the level of accuracy and availability needed for next-generation mobile services and time-sensitive low-latency applications. Featuring ADVA’s Oscilloquartz core grandmaster devices, enhanced primary reference time clock (ePRTC) technology and multi-band GNSS receivers, the new timing infrastructure is ultra-resilient and prepared to withstand the rising threat of jamming and spoofing attacks. ADVA’s partner RDT Equipment & Systems also played a significant role in the deployment, carrying out installation, configuration and troubleshooting. Together with ADVA, it will provide Partner Communication with ongoing maintenance and support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607006044/en/
“Upgrading a major nationwide mobile network like ours required the most advanced timing technology and the support of an expert team. That’s why we selected ADVA’s Oscilloquartz synchronization solution built on a core PTP grandmaster clock with full hardware redundancy and a scalable modular design. It offers many fan-out options, including PTP over multiple 10Gbit/s interfaces, and its advanced GNSS technologies ensure highest availability even under challenging conditions,” said Yigal Giladi, VP of engineering at Partner Communications. “With our new timing infrastructure, we can deliver the best possible mobile 5G experience to our customers. Now when GNSS is compromised or otherwise unavailable, ADVA’s ePRTC solution means we can still deliver phenomenally accurate timing across our network even during very long GNSS outages.”
Partner Communications’ new timing infrastructure features the OSA 5440 , a fully redundant, scalable, and modular multi-technology grandmaster for core deployment. Operating with the OSA 3230B ePRC cesium clock and OSA clock combiner, it provides an ePRTC system, providing high levels of time stability compliant with the ITU-T G.8272.1 standard. Onboard multi-band, multi-constellation receivers compensate for atmospheric disturbances to filter out timing errors. What’s more, centralized AI-powered GNSS assurance software identifies and protects against vulnerabilities of satellite-based timing. The solution also includes the OSA 5410 Series for continuous probing and assurance, enabling Partner Communications’ team to anticipate any issues and minimize disruption to service. The technology is remotely controlled by ADVA’s Ensemble Controller with Sync Director. This provides a powerful management platform, giving Partner Communications full visibility of its synchronization infrastructure and assuring accurate timing.
“Partner Communications has taken a major leap forward in terms of the accuracy and reliability of its synchronization network. Their team was determined to make their timing infrastructure the most precise and robust it could be, and so our engineers have worked tirelessly on design, testing and installation to ensure an end-to-end solution that delivers for Partner Communications’ customers now and for many years to come,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “This timing solution delivers a unique set of features to mitigate GNSS vulnerabilities, such as multi-band, multi-constellation receivers and AI-powered analytics. In a world of increasing jamming and spoofing attacks, this will prove invaluable for mobile users across Israel.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607006044/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press release
Intranasal pertussis vaccine candidate BPZE1 demonstrates robust nasal mucosal and systemic immune responses with a favorable safety profile in children ages 6 through 17 yearsFirst pediatric clinical trial builds on 5 prior adult BPZE1 clinical studiesDemonstrates safety and immunogenicity of BPZE1 in acellular pertussis vaccine primed individualsNo interference observed when BPZE1 co-administered with diphtheria and tetanus antigens ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The stu
NIQ Brings New AI and Automation Capabilities to Retail Space Planning and Merchandising2.10.2026 12:45:00 CEST | Press release
New AI and automation capabilities help retailers close execution gaps and scale merchandising decisions across every store. NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced new AI and automation capabilities for NIQ Spaceman®, its retail space planning and merchandising platform trusted by more than 600 retailers across 65+ countries. The enhancements help retailers create store-specific planograms up to 50 times faster, identify execution and compliance gaps, and scale merchandising decisions across their store networks through expanded cloud-based access. "Retailers are under increasing pressure to localize assortments, execute consistently across stores, and respond more quickly to changing shopper behavior," said Natalie Williams, SVP, Product at NIQ. "These enhancements help simplify that process by embedding agentic AI directly into merchandising workflows and automating traditionally manual planning tasks. That means teams can spend less time buil
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.10.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to one senior leader and ten newly hired non-executive employees. The equity awards for the senior leader were granted on September 30, 2026 and consisted of options to purchase an aggregate of 121,800 shares and restricted share units covering an aggregate of 58,000 shares. The options have an exercise price per share equal to $12.44. The equity awards to the ten newly hired non-executive employees were granted on October 1, 2026 and consisted of options to purchase an aggregate of 97,100 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 46,200 shares. These options have an exercise price per share equal to $11.95, the closing price of the Company’s American De
Global Health Leaders to Convene at Abu Dhabi Future Health Summit 20262.10.2026 12:24:00 CEST | Press release
Abu Dhabi Future Health Summit will convene leaders across healthcare, science, technology, policy, and investment from 20-22October at ADNEC Centre Abu DhabiUnder the 2026 theme ‘To Sense is to Predict’, the Future Health Summit will examine how greater health insight can enable earlier intervention and better outcomesAstraZeneca CEO Sir Pascal Soriot, Isomorphic Labs President Mr. Max Jaderberg, Amref Health Africa Group CEO Dr. Githinji Gitahi, and Health Ministers from Kosovo, Montenegro, Serbia and Colombia are among more than 130 Forum speakers, with participation expected from 100 countries Global leaders across healthcare, science, technology, policy, and investment will convene at the Abu Dhabi Future Health Summit from 20 to 22 October 2026 to examine how health systems can better anticipate risk and enable earlier intervention as advances in AI, genomics, diagnostics, and health data create new possibilities for understanding health risks earlier. This press release features
Venture Global and ConocoPhillips Announce 20-Year LNG Sales and Purchase Agreement1.10.2026 22:30:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) and ConocoPhillips (NYSE: COP) announced a new, long-term Sales and Purchase Agreement (SPA) for liquefied natural gas (LNG). Under the SPA, ConocoPhillips will buy 1.0 million tonnes per annum (MTPA) of LNG from Venture Global for 20 years, starting in 2030. "Venture Global is proud to welcome ConocoPhillips, one of the world's leading energy companies, as a long-term partner," said Venture Global CEO Mike Sabel. "This agreement reflects continued market confidence in our proven ability to deliver reliable, low-cost U.S. LNG quickly and at scale. We look forward to supporting ConocoPhillips' growing global LNG portfolio for decades to come." About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (LNG) with over 100 MTPA of capacity in production, construction, or development. Venture Global began producing LNG from its first facility in 2022 and is now one of the largest LNG exporters in th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
